NCT02895971

Brief Summary

The aim of this study estimate VTE incidence. Investigators prospectively record all cases of symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) of the lower limbs diagnosed between March 1, 2013 and February 28, 2014 in hospitals and in the community.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,416

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2013

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 12, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
Last Updated

July 5, 2017

Status Verified

July 1, 2017

Enrollment Period

4.3 years

First QC Date

August 29, 2016

Last Update Submit

July 3, 2017

Conditions

Venous Thromboembolism

Keywords

Venous Thromboembolismprofessional Practices

Outcome Measures

Primary Outcomes (1)

  • Gathering information about potential factors predisposing Thromboembolic disease and treatments undertaken.

    After two years, all medication given to the patient to treat his initial VTE will be recorded, as well as the ongoing of thromboembolic disease

    two years after VTE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patient with venous thromboembolism

You may qualify if:

  • symptomatic pulmonary embolism (PE) and deep vein thrombosis (DVT) diagnosis confirmed
  • Patient living in Brest area from time of diagnosis

You may not qualify if:

  • invalid diagnosis
  • asymptomatic event
  • Main residence patient out of Brest area.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU de Brest

Brest, 29609, France

Location

MeSH Terms

Conditions

Venous Thromboembolism

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2016

First Posted

September 12, 2016

Study Start

March 4, 2013

Primary Completion

June 30, 2017

Study Completion

June 30, 2017

Last Updated

July 5, 2017

Record last verified: 2017-07

Locations

FR(1)